Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C24H22N6O4 and a molecular weight of approximately 458.47 g/mol[1][3][8]. It belongs to the class of diphenylethers and features both phenoxypenyl and pyrimidinylpiperazine moieties attached to a pyrimidine trione core[1][7]. The compound is listed in drug databases as an experimental molecule but does not have an assigned therapeutic indication or known mechanism of action in clinical use. Its structure has been studied as a ligand in protein-ligand interaction research (notably PDB ligand code "4MR"), suggesting utility primarily as a chemical probe or fragment for structural biology studies rather than as an approved pharmaceutical agent[3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-(4-phenoxyphenyl)-5-(4-pyrimidin-2-ylpiperazin-1-yl)pyrimidine-2,4,6(2H,3H)-trione.